Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

CELZ Relative to the S&P 500

CELZ Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Creative Medical Technology Holdings Inc (NASD:CELZ) seasonal charts above shows that a Buy Date of February 3 and a Sell Date of May 15 has resulted in a geometric average return of 25.22% above the benchmark rate of the S&P 500 Total Return Index over the past 14 years. This seasonal timeframe has shown positive results compared to the benchmark in 7 of those periods. This is a poor rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 14 years by an average of 125.22% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.

To download CELZ seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: CELZ